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Abstract
Perlecan is a modular, multifunctional heparan sulphate-proteoglycan (HS-PG) that is present in the 
pericellular and wider extracellular matrix of connective tissues. In the present study, confocal microscopy 
was used to study perlecan distribution within intervertebral disc chondrons. Perlecan immunolabel was 
demonstrated intracellularly and in close association with the cell nucleus within chondrons of both the 
annulus fibrosus (AF) and nucleus pulposus (NP). This observation is consistent with earlier studies that have 
localised HS-PGs with nuclear cytoskeletal components. Nuclear HS-PGs have been proposed to transport 
fibroblast growth factor (FGF)-1, FGF-2 and FGFR-1 into the cell nucleus, influencing cell proliferation and 
the cell-cycle. Perlecan has well-known interactive properties with FGF family members in the pericellular 
and extracellular matrix. Perinuclear perlecan may also participate in translocation events with FGFs. The 
glycosaminoglycan side chains of HS-PGs can modulate chromatin structure by regulating the access of 
transcription factors to DNA. These mechanisms are consistent with the distribution patterns identified 
here and previously reported for other HS-PGs, introducing a potentially-novel arena for perlecan in gene 
regulation. Whilst much is known of the structure and function of perlecan in the pericellular and extracellular 
matrix, very little is known of any intracellular forms of perlecan. The perlecan labelling patterns described 
here suggest the possibility of involvement of this HS-PG in an intracrine regulatory system. Future studies 
should further explore this possibility and the potential for this HS-PG as a novel therapeutic target.
Keywords: Perlecan, intracellular, heparan sulphate, intervertebral disc, Wnt signalling pathway, fibroblast 
growth factor-2, fibroblast growth factor receptor-1.
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list of Abbreviations
3D   3 dimensional
ADAMTS a disintegrin and metalloproteinase  
   with thrombospondin motifs
AF   annulus fibrosus
AFM  atomic force microscopy
BMP  bone morphogenetic protein
CS   chondroitin sulphate
DAPI  4′,6-diamidino-2-phenylindole
DIC  differential interference contrast
DS   dermatan sulphate
ECM  extracellular matrix
FGF  fibroblast growth factor
FGFR  fibroblast growth factor receptors
GAG  glycosaminoglycan
GPC  glypican
HIF-1α  hypoxia inducible factor-1α
HS   heparan sulphate
HSPG2  perlecan
IL-1β  interleukin-1β
IVD  intervertebral disc
74 www.ecmjournal.org
AJ Hayes et al.                                                                                     Nuclear and cytoplasmic localisation of perlecan
MMP-1,2 and 9 matrix metalloproteinase-1,-2 and -9
NCAM  neural cell adhesion molecule
NF-κB  nuclear factor kappa-light-chain-  
   enhancer of activated B cells
NP  nucleus pulposus
PBS  phosphate buffered saline
PCM  pericellular matrix
PDGF  platelet-derived growth factor
PG   proteoglycan
PHDs  prolyl hydroxylases
ROI  region of interest
SDC-1,2 & 4 syndecan-1, -2 and -4
SEA  sperm protein-enterokinase agrin
TGF-β  transforming growth factor β
TNF-α  tumour necrosis factor α
VEGF  vascular endothelial growth factor
VEGFA  vascular endothelial growth factor A
VEGFR-2 vascular endothelial growth factor  
   receptor-2
Wnt  wingless-related integration site
convey mechanosensory cell signalling properties 
to the strings of cells interconnected by perlecan in 
the AF (Hayes et al., 2011a). Pericellular perlecan 
plays a cytoprotective role in cartilage chondrons 
and would convey similar beneficial properties 
to IVD cells, providing protection from the harsh 
biomechanical environment encountered in the 
disc during gait (Wilusz et al., 2012). Perlecan is also 
involved in the co-acervation of tropoelastin, as part 
of the elastic microfibril assembly process at the cell 
surface in the AF (Hayes, 2011a). As stated, perlecan 
is a multifunctional PG and interacts with collagen 
types VI (Hayes et al., 2016) and type XI within the 
PCM compartment (Smith and Melrose, 2019) to 
stabilise the chondron structure. It also interacts with 
a variety of structural and cell-adhesive glycoproteins 
at the cell surface and within the wider ECM (Gomes 
et al., 2004; Knox and Whitelock, 2006; Melrose et al., 
2008a and b; Melrose et al., 2006). Perlecan has cell-
directive properties, promoting the proliferation and 
differentiation of disc cells through its ability to act 
as a low affinity co-receptor for a number of growth 
factors including members of the FGF family, VEGF, 
PDGF and BMP-2 and 4 (Lord et al., 2014; Whitelock 
et al., 2008). Perlecan facilitates complex formation 
between FGF family members and their FGFRs 
resulting in activation of the FGFRs, which directs cell 
signalling events that drive tissue expansion during 
IVD development (Lord et al., 2014; Melrose et al., 
2003; Whitelock et al., 2008). Interestingly, some HS-
PG family members have been shown to be shuttled 
into the nucleus of cells where they interact with 
nuclear FGF-1, 2 and FGFRs to regulate the cell-cycle, 
mitosis and cellular proliferation (Kovalszky et al., 
2014). Of relevance, perlecan has been shown to exist 
as a nuclear component in neurons and glial cells 
where it has been proposed to modulate astrocyte 
activity during astrogliotic events accompanying 
traumatic brain injury (Leadbeater et al., 2006).
 During studies on the IVD, many research groups 
have characterised a number of roles for PCM and 
ECM perlecan in the pathobiology of the IVD (Gomes 
et al., 2004; Kirn-Safran et al., 2009; Knox et al., 2006; 
Melrose et al., 2008a). In one of the studies, the 
presence of intracellular perlecan immunolabelling 
was identified within IVD tissues. The present 
study followed up on these initial observations, by 
characterising the 3D distribution and organisation 
of perlecan within IVD chondrons to examine the 
potential roles it plays in the regulation of IVD cells. 
The rationale for this study originated from earlier 
observations on nuclear HS-PGs in a number of 
cell types and the documented roles for perlecan 
as an instructive PG that directs many aspects of 
the metabolism of connective tissue cells, ECM 
organisation and stabilisation. There was particularly 
interested in the potential roles that perlecan may 
play in the control of IVD-cell behaviour through 
direct effects on nuclear organisation and gene 
regulation, as this might represent an area to target 
in future interventional therapeutic measures. 
introduction
Perlecan (HSPG2) a large modular, multifunctional HS 
or HS/CS hybrid PG has a pericellular or extracellular 
tissue distribution in a number of connective tissues 
(Melrose et al., 2006; Melrose et al., 2008a; Smith 
et al., 2010). It is a 5-domain, cell-regulatory PG 
displaying homology with the SEA domain, laminin 
G domains, NCAM-like immunoglobulin repeats, 
epidermal growth factor-like modules (Cohen et al., 
1993; Murdoch et al., 1992; Noonan et al., 1991) and is 
capable of interacting with a diverse range of growth 
factors, morphogens, ECM components, proteases 
and protease inhibitory proteins (Melrose et al., 2008a; 
Melrose et al., 2006). Functions ascribed to perlecan 
include sequestration of a number of different 
growth factors, with perlecan acting as a co-receptor: 
matrix stabilisation; modulation of tissue fibrosis 
through control of platelet function; promotion and 
inhibition of angiogenesis (Lord et al., 2014); assembly 
of the neuromuscular junction controlling muscle 
activity; assembly and stabilisation of the basement 
membrane and blood vessel vasculature (Breitkreutz 
et al., 2013; Nakamura et al., 2019) and regulation of 
collagen fibrillogenesis (Kvist et al., 2006). Perlecan 
is also associated with the development of a 
number of tumours through its ability to promote 
angiogenesis, but also contains bioactive anti-
angiogenic peptide modules within domain V that 
antagonise VEGFA-VEGFR-2 interactions and the 
interaction of endothelial cells with α2β1 integrin, 
inhibiting tube formation (Lord et al., 2014).
 AFM studies have shown that pericellular 
perlecan has biomechanical properties in articular 
cartilage through interaction with type VI collagen, 
a major component of the chondron basket-like 
structure, and it is therefore likely to play similar roles 
in IVD function (McLeod et al., 2013; Wilusz et al., 
2012). Perlecan co-localises with elastic microfibrils in 
the AF and imparts compliancy to this collagen-rich 
tissue (Hayes et al., 2011b). Elastic microfibrils also 
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Consequently, the aim was to map the 3D labelling 
patterns of perlecan both within and outside of 
the cell in the different IVD tissues and to review 
potential functional implications of these labelling 
patterns on IVD-cell metabolism, based on published 
information on this interesting multifunctional HS-
PG. To this end laser scanning confocal microscopy 
was used to evaluate the 3D distribution and 
organisation of perlecan in histological sections of 
ovine IVD using an antibody to perlecan domain IV. 
Here, stacks of serial optical sections are presented, 
taken at approximately 0.5 µm steps through the full 
volume of individual disc chondrons from AF and 
NP, as well as 3D models of the reconstructed stacks 
to provide accurate spatial information of perlecan 
distribution and organisation within the different 
discal regions. Furthermore, compelling evidence is 
provided to suggest the intracellular localisation of 
perlecan.
materials and methods
Rat monoclonal anti-perlecan domain-IV (A7L6) 
(ab2501) antibody was obtained from Abcam, 
Cambridge, UK. Rabbit polyclonal anti-type VI 
collagen antisera (VIb) was a gift from Dr Shirley 
Ayad, Manchester University (Ayad et al., 1989). 
Vectorshield tissue mountant containing DAPI 
was purchased through Vector Laboratories, 
Peterborough, UK.
intervertebral disc tissues
6, 2-year old merino wether sheep (castrated males) 
from a single flock were obtained for these studies 
from a local animal sale yard. Sheep were sacrificed 
with an overdose of pentobarbital and lumbar 
spinal IVD segments (L1L2 to L6L7) were excised. 
Individual IVDs containing segments of the superior 
and inferior vertebral bodies still attached were 
excised using a bone saw and the IVDs were fixed en 
bloc in 10 % v/v neutral buffered formalin and then 
decalcified. This processing ensured that swelling 
artefacts were minimised in the IVD specimens. An 
unconstrained IVD fixation/decalcification results in a 
severe distortion in authentic tissue architecture due 
to artefactual swelling (Melrose et al., 2008c). Fixed/
decalcified 5 mm thick tissue slabs were cut and 
embedded in paraffin wax and vertical mid-sagittal 
microtome sections (7 µm) were prepared for confocal 
analysis. The animals used were skeletally mature, 
had been treated with a broad range anti-parasitic 
program, were bright eyed, and had good skeletal 
form with appropriate muscle to fat proportions. 
They also displayed correct ambulation, while their 
feeding and flocking behaviour were unremarkable. 
Therefore, the sheep were fit and healthy. All animal 
welfare and ethics for this work were approved by 
the University of Sydney Animal Care and Ethics 
Committee under ethics approval A45/6-2011/3/5544.
histological processing and immunohistochemistry
Tissue sections were deparaffinised in graded ethanol 
washes to water. IVD sections were stained for 10 min 
with 0.04 % (w/v) toluidine blue in 0.1 mol/L sodium 
acetate buffer, pH 4.0 followed by a 2-min counterstain 
in 0.1 % (w/v) fast green FCF. Sections were also 
stained in Mayer's haematoxylin (5 min), rinsed in 
tap water blued in Scott's blueing solution (1 min) 
and counterstained in 0.0001 % (w/v) eosin (5 min). 
Sections were washed for 3 × 5 min in 0.1 mol/L PBS at 
pH 7.4 containing 0.01 % TWEEN 20 (Merck, Dorset, 
UK), which was also used as a diluent for all immuno-
reagents. Sections were either labelled for perlecan 
alone or were dual labelled in sequence for perlecan 
and type VI collagen. For perlecan localisations, 
non-specific antibody binding was blocked using 
donkey serum (Agilent Technologies, Stockport, 
UK) and, for type VI localisations, goat blocking 
serum (Agilent Technologies) was used, both at 1 : 20 
dilution for 30 min at room temperature. Perlecan was 
immunolocalised overnight at 4 °C using a rat anti-
perlecan domain IV (MAb A7L6) antibody (Abcam) at 
1 : 50 dilution; type VI collagen was immunolocalised 
for 2 h at room temperature using a rabbit anti-type VI 
collagen polyclonal antibody (2 µg/mL) – a gift from 
Dr Shirley Ayad, Manchester University (Ayad et al., 
1989). After labelling, sections were washed in PBS, 
as described, and primary antibody binding detected 
with an Alexa 594-conjugated donkey anti-rat 
secondary antibody for perlecan (red fluorescence) 
(ThermoFisher Scientific, Loughborough, UK), 
and an Alexa 488-conjugated goat anti-rabbit 
secondary antibody for type VI collagen (green 
fluorescence) (ThermoFisher Scientific), both used 
at 1 : 200 dilution for 1 h at room temperature. After 
washing, tissue sections were mounted under glass 
histology coverslips using Vectashield mountant 
containing DAPI to counterstain the cell nuclei (blue 
fluorescence) (Vector Laboratories). Negative-control 
slides were similarly processed but the primary 
perlecan antibody was omitted or was replaced with 
an irrelevant antibody. All controls showed no non-
specific antibody binding.
Confocal laser scanning microscopy
Fluorescently-labelled IVD tissue sections were 
scanned on a Leica TCS SP2 AOBS laser scanning 
confocal microscope (Leica, Heidelberg, Germany) 
using 40 × and 63 × oil-immersion objectives. To 
eliminate spectral bleed-through between fluorescent 
dyes, samples were scanned sequentially using 
appropriate excitation and emission settings for DAPI 
(Ex. max., 359 nm; Em. max., 461 nm; blue nuclear 
fluorescence) and Alexa 594 (Ex. max., 594 nm; Em. 
max., 618 nm; red perlecan fluorescence) or DAPI, 
Alexa 594 and Alexa 488 (Ex. max., 488 nm; Em. 
max., 510 nm; green type VI collagen fluorescence) 
for dual-immunolocalisation experiments. Z-stacks of 
8-bit ‘optical sections’ (512 × 512 pixels) were taken 
through the full thickness of the IVD tissue sections 
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at a spacing of approximately 0.6 µm increments 
using Leica Confocal Software (Leica, Heidelberg, 
Germany) and used to prepare gallery images of the 
perlecan and DAPI localisations and videos of these 
sequential image sequences were also prepared.
3D reconstruction of confocal Z-stacks
Confocal image datasets were also imported into 
Imaris for Cell Biologists software (Bitplane, Oxford 
Instruments, Zurich, Switzerland) for 3D processing 
and fluorescent localisation analysis. To conceptualise 
the fluorescent labelling patterns in 3D space, Z-stacks 
were modelled using maximum intensity and surface 
coding reconstruction algorithms. To contextualise 
the 3D-labelling pattern of perlecan in relation to type 
VI collagen, overlay images were created in which 
the type VI collagen channel was rendered semi-
transparent with respect to the underlying perlecan 
channel (red).
results
Vertical sections of ovine IVDs stained with toluidine 
blue-fast green, which was used to delineate PG 
localisation (Fig. 1a,c), and haematoxylin and eosin 
(Fig. 1b,d), used to reveal cellular morphology, 
indicate the main ROIs in the present study, i.e. outer 
AF and NP. Representative ROIs of NP and AF are 
indicated using the boxed areas shown. A schematic 
figure of a representative chondron containing 2 disc 
cells has been provided to clarify the major structural 
features of a chondron using terminology proposed 
by Pritzker and Aigner (2010) (Fig. 1e).
 Sequential analysis of optical sections from 
confocal Z-stacks revealed the spatial organisation 
of perlecan within chondrons of the AF and NP 
of the IVD (Fig. 2). Perlecan label was distributed 
diffusely within the territorial matrix compartment 
but was highly prominent pericellularly, forming a 
well-defined zone around disc cells (Fig. 2). Video 
sequences through the Z-stacks, depicted in Fig. 
2, are also presented as supplementary videos to 
better convey perlecan’s 3D distribution within the 
chondron in the 2 distinct discal regions. In selected 
sections, perlecan immunofluorescence appeared to 
extend from the pericellular matrix into the lacunar 
space occupied by the disc cell, often manifesting as 
intense punctate foci (Fig. 3). Higher magnification 
images (Fig. 4) showed a distinct band of perlecan 
immunofluorescence, surrounding the cell that was 
in close association with the cell nucleus and a thin 
perlecan-negative discontinuity separated this band 
of fluorescent label from an adjacent outer zone of 
perlecan positive matrix further enveloping the cell. 
Dual-labelling experiments (see below) indicated that 
this discontinuity within the chondron capsule was 
occupied by collagenous ECM material, particularly 
type VI collagen. Intense foci of perlecan label were 
also evident throughout the territorial matrix (Fig. 
4a,b). These features are explained in Fig. 1e.
 A superficial section taken through a single 
chondron within the NP demonstrated the presence 
of large perlecan-positive vesicular structures; 
whilst deeper sections within the image stack, taken 
through the chondrocyte itself, showed the presence 
of punctate foci, characteristic of intracellular vesicles, 
that were closely associated with the cell nucleus 
(Figs. 5, 6). In many of the cells examined, pericellular 
perlecan enveloped the cell nucleus so tightly that it 
was difficult to identify the lacunar space; however, 
in some examples the lacunar margins could be 
clearly delineated when the cell had artefactually 
shrunk due to histological processing (Fig. 7e-o). 
Higher power examination of such images clearly 
showed the pericellular localisation of perlecan at the 
lacunar margins (Fig. 8a) and indicated the presence 
of small intracellular perlecan positive foci that were 
closely associated with the cell nucleus (Fig. 8e). 
These features were consistently noted in Z-stacks 
taken through other chondrons of the disc (Fig. 9). 
Detailed examination of selected image planes (e.g. 
Fig. 9h,k,l), showed the presence of punctate foci of 
perlecan fluorescence within the lacunar space and 
in intimate association with the cell nucleus (shown 
in detail in Fig. 10a-c). In the chondron shown in 
Fig. 10, Nomarski DIC observation of the blebbing 
cell membrane indicated that the punctate labelling 
pattern was intracellular (Fig. 10d-f).
 In order to delineate the 3D-spatial organisation 
of perlecan within the disc chondrons, selected 
confocal Z-stacks were reconstructed as maximum 
intensity and surface-coded 3D models. Examination 
of the 3D reconstructed models in silico confirmed 
the 2D-spatial information identified from the stack 
views, showing interstitial, pericellular, and punctate 
intracellular labelling patterns (Fig. 11a-c). The 
intimate association of perlecan label with the cell 
nucleus was striking in the 3D projection views (Fig. 
11); however, the punctate labelling pattern was less 
distinct than that observed in the 2D-optical sections 
due to interference from overlying structures in the 
focal plane (Fig. 11c).
 Dual-confocal immunolocalisation of type VI 
collagen and perlecan established the close inter-
relationship between these components in relation to 
the cells within the chondron structure (Fig. 12a,d). 
Type VI collagen and perlecan were co-distributed 
in the chondron and co-localised pericellularly, as 
demonstrated in 3D-overlay models, (Fig. 12b). 
Rendering the green fluorescence channel semi-
transparent revealed the overlapping distributions of 
type VI collagen and perlecan around the cells (Fig. 
12c) and showed that type VI collagen extended a 
greater distance from the cell into the inter-territorial 
ECM. Closer examination of the 3D-surface-rendered 
models revealed what appeared to be budding 
protrusions of perlecan, believed to represent 
vesicular deposits destined for matrix secretion.
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fig. 1. histology of ovine ivD. Vertical sections of ovine IVD stained with toluidine blue-fast green (a,c) and 
haematoxylin and eosin (b,d) showing the composite disc tissues. Boxed areas indicate representative ROI 
within the outer annulus (oa) and nucleus pulposus (np). ia, inner annulus; gp, growth plate; vb, vertebral 
body. (e) Schematic representation showing the structural features of a chondron based on observations 
made by Poole CA (1997-2008) and using terminology proposed by Pritzker and Aigner (2010) Inset shows 
immunolocalisation of pericellular perlecan. Image (e) reproduced from Gahunia and Pritzker (2020) 
with permission from Springer-Nature Publishers under licence number 4936150221393. 1, cell nucleus 
of chondrocyte; 2, chondrocyte cytoplasm; 3, chondrocyte plasma membrane; 4, lacuna space; 5, pericellular 
matrix; 6, fibrous pericellular capsule; 7, territorial matrix; 8, wider inter-territorial ECM.
 Videos of sequential perlecan immunolocalisations 
through the full cell depth are also shown for the 
string of AF cells and single NP cell, depicted in Fig. 
2. Supplementary videos 1 and 2 are available from 
the paper website. These videos clearly show the 
spatial distributions of perlecan in the specimens.
Discussion
the concept of the chondron as a structural 
functional entity in articular cartilage and ivD
The chondron concept was first introduced by 
Benninghoff (Benninghoff, 1925) who used polarised 
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fig. 2. perlecan location in Af and np cells. Composite image depicting perlecan immunofluorescence (red) 
in sequential optical sections of confocal Z-stacks through chondrons of the AF (left panel; a-s; sections # 1-19) 
and NP (right panel; a-t; sections # 1-20) of ovine IVD. Nuclear counterstaining in blue. The optical sections 
have been sampled at 0.6 µm increments through the full depth of the tissue section (Z position shown at 
bottom right of each image). The AF cell labelled c in section # 9 (i) is shown at higher magnification in Fig. 3 
and followed from section # 7 through to # 10. Similarly, the NP cell shown is depicted at higher magnification 
in Fig. 4. Perlecan has a prominent pericellular distribution (P) with punctate foci identifiable within the 
lacunar space (refer to Fig. 3). Negative controls (bottom right panels) taken at low and high power indicate 
no non-specific labelling for perlecan. Scale bars 25 µm. Sequential images of the AF and NP cells are also 
provided as videos in supplementary videos 1 and 2.
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fig. 3. selected confocal optical sections through 
Af. (a-d) Selected confocal optical sections (# 7, 8, 
9, 10) through an AF chondron immunolabelled for 
perlecan (red). Z position shown at bottom right of 
each image. Note prominent labelling of perlecan in 
pericellular matrix with bright foci at cell margins 
and adjacent to the nucleus. Nuclear counterstaining 
in blue. (e) Transmitted light image of chondron 
obtained by Normaski DIC optics. (f) Fluoresence/
DIC overlay image. (g) Schematic showing chondron 
structure. n, nucleus; PCM, pericellular matrix. Scale 
bars 25 µm.
fig. 4. selected confocal optical sections through 
np. (a,b) Selected confocal optical sections (# 6, 
# 7 of Fig. 2, right panel) through an NP chondron 
immunolabelled for perlecan (red). Z position 
shown at bottom right of each image. Cell nuclei 
counterstained blue. PC, denotes position of 
pericellular capsule (white arrows). Note also 
pericellular perlecan (P) and foci deposits (F) 
labelled with yellow arrows while asterisks indicate 
more removed foci. (c) Transmitted light image of 
chondron obtained by Normaski DIC optics. (d) 
Schematic showing chondron structure. n, nucleus; 
PCM, pericellular matrix. Scale bars 25 µm.
light microscopy to demonstrate that the chondrocyte 
was surrounded by a specialised structure which he 
termed the chondrone. Interest in the chondron waned 
until 1969 (Szirmai, 1969) and 1974 (Szirmai, 1974) 
when interest was rekindled in this structure. More 
recently, Poole et al. published an extensive series 
of publications on cartilage chondrons (McGlashan 
et al., 2008; Poole, 1990a; Poole, 1993; Poole, 1997; 
Poole et al., 1984; Poole et al., 1985a; Poole et al., 
1985b; Poole et al., 1987; Poole et al., 1988a; Poole et 
al., 1988b; Poole et al., 1988c; Poole et al., 1990b; Poole 
et al., 1991a; Poole et al., 1991b;). In 2010, Pritzker and 
Aigner proposed some definitions for the features 
evident in a chondron (Pritzker and Aigner, 2010). 
The Pritzker and Aigner terminology was adopted 
in the present study and an explanatory figure is 
provided to indicate the chondron’s major structural 
features using this terminology (Fig. 1e). The 3D 
features of chondrons in the IVD have also been 
described (Cao et al., 2007) and variation in chondron 
morphology measured using confocal microscopy 
immunolocalisation of type VI collagen, which 
conveniently delineates the extent of the chondron 
structure (Youn et al., 2006). Perlecan also colocalises 
with type VI collagen in the chondron (Hayes et al., 
2016) and has biomechanical properties (Wilusz 
et al., 2012) and, as shown in the present study, 
is localised in the PCM surrounding the disc cell 
within the chondron. Perlecan is a multifunctional 
PCM and ECM PG, where it stabilises these tissue 
compartments through its interactive properties with 
other matrix components. Perlecan also sequesters a 
number of growth factors, stimulates chondrogenesis 
and controls the proliferation and differentiation 
of chondrocytes and disc cells (Farach-Carson and 
Carson, 2007; Gomes et al., 2004; Knox et al., 2006; Lord 
et al., 2014; Melrose et al., 2006; Melrose et al., 2008a; 
Melrose, 2020). Perlecan also colocalises with elastin in 
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fig. 5. perlecan immunofluorescence in np 
chondron. (a-t) Composite image depicting perlecan 
immunofluorescence (red) in sequential optical 
sections of confocal Z-stack through a NP chondron 
(sections # 1-20). Z position shown at bottom right of 
each image. Nuclear counterstaining in blue. White 
arrowheads highlight position of large perlecan-
positive structures within chondron. White arrows 
denote punctate perlecan immunolabel closely 
associated with the cell nucleus. Sections # 3, 11 and 
16 (c, k, p) are presented at higher magnification in 
Fig. 6. Scale bars 25 µm.
fig. 6. selected high magnification images of 
perlecan immunofluorescence in an NP chondron. 
(a-c) Selected confocal optical sections (Fig. 5c,k,p) 
taken through a NP chondron immunolabelled for 
perlecan (red). Z position shown at bottom right 
of each image. Cell nuclei counterstained blue. (c) 
Presence of large perlecan-positive structures (white 
arrowheads) visible in superficial plane through 
chondron (section # 3). (b,c) Punctate perlecan 
immunolabel (white arrows) intimately associated 
with the cell nucleus and its margins (asterisks) 
(section # 11 and 16). Scale bars 25 µm.
in the chondron and also in translamellar cross-
bridge structures that serve as internal stabilising 
struts between non-adjacent annular lamellae and 
also contain fibrillin-1, elastin and perlecan (Hayes 
et al., 2016; Melrose et al., 2008b; Yu et al., 2015). The 
PCM is a strategic interface that links the disc cell 
with the adjacent extracellular micro-environment, 
and facilitates mechano-transductive responses by 
the disc cell that regulate disc tissue composition and 
function. Such interactions are therefore important in 
the maintenance of normal disc tissue homeostasis. 
Perlecan also has cytoprotective properties, 
protecting the disc cell from its harsh biomechanical 
microenvironment and conditions of low pH, oxygen 
tension and nutrition (Wilusz et al., 2012; Wilusz et 
al., 2014). Videos prepared to depict the sequential 
immunolocalisations of perlecan through the full 
depth of AF and NP cells enclosed in their chondrons 
provide complimentary visual information to the 
confocal perlecan immunolocalisations provided 
elsewhere in this study (see supplementary videos 
1 and 2 on the paper website).
vascularised tissues and has roles in the coacervation 
of tropoelastin at the surface of AF cells, thereby 
contributing to assembly of fibrillin and elastin in 
elastic microfibrils (Hayes et al., 2011a; Hayes et al., 
2011b; Hayes et al., 2013; Hayes et al., 2014). Perlecan 
also has interactive properties with type VI collagen 
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fig. 7. perlecan immunofluorescence in np 
chondron. (a-r) Composite image depicting perlecan 
immunofluorescence (red) in sequential optical 
sections of confocal Z-stack through a NP chondron 
(sections # 1-18). Z position shown at bottom right of 
each image. Nuclear counterstaining in blue. (h-m) 
Lacuna space denoted by asterisk in sections # 8-13; 
margins of the lacuna indicated with dotted lines. 
(h,i) White arrows (sections # 8-9) indicate punctate 
perlecan label associated with the cell nucleus. (l-
o) white arrowheads (sections # 12-15) highlight 
position of pericellular perlecan within chondron 
capsule. h and l are shown in detail in Fig. 8. Scale 
bars 25 µm.
fig. 8. Selected high magnification images of perlecan 
immunofluorescence in an NP chondron. (a) Detail 
of Fig. 7l, showing perlecan immunolocalisation (red) 
within a chondron of the NP. Nuclear counterstaining 
in blue. Z position shown at bottom right of image. 
White arrowheads indicate position of pericellular 
perlecan within chondron capsule. (b) Transmitted 
light (DIC) image. (c) Fluorescence/DIC overlay 
image. (d) Schematic showing zonal structure of 
chondron. (e) Detail of Fig. 7h, showing perlecan-
positive foci within the cell nucleus (white arrows). 
Scale bars 25 µm.
FGFR-3 (Melrose et al., 2003). Perlecan also interacts 
with type VI collagen and type XI collagen and has 
roles in the stabilisation of the disc cell PCM. Perlecan 
has not previously been shown to be an intracellular 
PG and may have previously unidentified roles 
to play in disc cell regulation through effects on 
nucleosomal organisation and transcription factor 
regulation. The current studies demonstrated a 
vesicular labelling pattern of perlecan within cells 
of both the NP and AF of the disc, with foci of 
perlecan immunolabel occurring in close association 
with the cell nucleus. A similar punctate labelling 
pattern of perlecan was also noted in the capsular 
matrix surrounding the disc cells. Although further 
work is required to substantiate these observations, 
the labelling patterns suggest that perlecan may be 
trafficked, by transport vesicles, between the cell 
nucleus and extracellular environment where it has 
established roles in disc cell regulation.
nuclear hs-proteoglycans
ECM HS-PGs have been observed to be shuttled 
to the nucleus in many cell types (Kovalszky et al., 
 Perlecan has previously been shown to be a 
pericellular component of AF and NP cells and has 
roles in the development of the IVD through its ability 
to undergo cell signalling with FGF-2, FGF-18 and 
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fig. 9. perlecan immunofluorescence in np 
chondron. (a-p) Composite image depicting perlecan 
immunofluorescence (red) in sequential optical 
sections of confocal Z-stack through a NP chondron 
(sections # 1-16). Nuclear counterstaining in blue. Z 
position shown at bottom right of each image. White 
arrows with asterisks indicate perlecan-positive foci 
at nuclear margins, single arrows depict foci further 
removed from the nucleus. Selected images from 
this composite are depicted in detail in Fig. 10. Scale 
bars 25 µm.
fig. 10. selected high magnification images of 
perlecan immunofluorescence in an NP chondron. 
(a,b,c) Selected sections from Fig. 9 showing punctate 
labelling of perlecan (red) within a chondron of the 
NP. White arrows indicate perlecan-positive foci 
within the chondron capsule, in the nuclear margins 
(asterisks). Nuclear counterstaining in blue. Z position 
shown at bottom right of each image. (d) Transmitted 
light DIC image of chondron (e) Fluorescence/DIC 
overlay image (f) Schematic illustrating position of 
cell nucleus (n) depicting cell margin, denoted by 
blebbing cell membrane (solid line), and margin of 
capsular matrix (dashed line). Scale bars 25 µm.
transcription factor, correlates with translocation 
of SDC-1 to the nucleus in prostate cancer cell lines 
(Farfán N et al., 2020). The function of nuclear SDC-1 
is unclear; however, it has been proposed to inhibit 
histone acetyltransferase and lead to chromatin 
compaction (Purushothaman et al., 2011), decreasing 
DNA accessibility to transcription factors, effecting 
cell cycle control, decreased proliferation and the 
regulation of transcriptional machinery and protein 
transport to the nucleus (Kovalszky et al., 2014).
biosynthesis of proteoglycans
PG biosynthesis involves the synthesis of a protein 
core in the rough endoplasmic reticulum, followed 
by post-transitional addition of GAG in the smooth 
membrane systems (Geetha-Habib et al., 1984; 
Ratcliffe et al., 1985) of the Golgi complex (Kimura et 
al., 1984). The PG is then exported to the extracellular 
environment in vesicles. The perinuclear (Golgi) 
region of chondrocytes is the major site of radio-
sulphate incorporation (Godman and Lane, 1964; 
Kimata et al., 1971) and of proteoglycan and GAG 
localisation (Pacifici et al., 1983; Ratcliffe et al., 1985; 
Song et al., 2020; Vertel and Dorfman, 1978; Vertel 
and Dorfman, 1979; Vertel and Barkman, 1984). 
Addition of xylose to the core protein linkage region 
is a late endoplasmic reticulum or early Golgi event 
(Lohmander et al., 1986) and step-wise addition of 2 
2014; Ricard-Blum and Gondelaud, 2016; Stewart 
and Sanderson, 2014). GPC has been identified in 
the nucleus of neurons and glioma cells (Liang et 
al., 1997), SDC-4 in the nucleus of cardiomyocytes, 
SDC-1 in fibrosarcoma cells and SDC-2 to the nucleus 
of tumour cells in osteochondromas (Schrage et al., 
2009). Increased expression of Snail, a repressor 
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galactose residues then occurs followed by a GlcA 
residue to complete the Xyl-Gal-Gal-GlcA linkage 
region. The Xyl-Gal-Gal-GlcA tetrasaccharide 
linkage region acts as an acceptor molecule for the 
subsequent assembly of HS, CS and DS GAG chains 
through the co-ordinated and sequential action 
of a number of sulpho- and glycosyl transferase 
and synthase enzyme systems (Ethen et al., 2015; 
Sasarman et al., 2016). The vesicular perinuclear 
localisation of perlecan that was observed in the 
present study may thus represent endogenously-
produced perlecan destined for secretion from the 
cytoplasmic compartment into the pericellular matrix 
environment of the chondron. The intranuclear 
localisation of perlecan-positive vesicles identified in 
confocal Z-stacks suggested a potentially novel role 
for this multifunctional PG.
fgf-1 and fgf-2 in the nucleus
FGF-2 is a member of the large FGF family of growth 
factors that bind heparin and HS and have modulatory 
effects on a wide range of cell types. FGF-2 stimulation 
of endothelial cells induces normal wound healing 
and tissue development through new blood vessel 
development in healthy tissues; however, it can also 
promote pathogenic conditions such as cancer and 
atherosclerosis. Growth factors translocated from the 
cell surface, such as FGF-2, can be imported into the 
nucleus and have direct biological roles regulated 
by nuclear HS-PGs (Levine and Prystowsky, 1995). 
FGFRs can also enter the nucleus during the cellular 
transition between proliferation and differentiation. 
Once nuclear, FGFRs may interact with chromatin 
remodelling proteins which alter the epigenetic state 
and transcriptional status of target genes (Tuzon et 
al., 2019).
nuclear heparan sulphate proteoglycans
The presence of nuclear HS-PGs has been 
demonstrated by many studies over the last 5 decades 
(Fedarko et al., 1989; Hsia et al., 2003; Ishihara and 
Conrad, 1989; Ishihara et al., 1986) and correlated 
with cell proliferation (Fedarko et al., 1989). Nuclear 
HS-PGs also have shuttling properties for protein 
kinase C-dependent nuclear localisation of FGF-2, 
shown to occur following corneal trauma (Hsia et 
al., 2003). FGF-2 is also an extracellular mechano-
transductive chondro-protective effector molecule in 
cartilage (Vincent and Saklatvala, 2006; Vincent et al., 
2007). Nuclear HS-PGs inhibit DNA topoisomerase 
I activity, which has important roles to play in the 
removal of DNA supercoils during transcription 
and DNA replication; in the re-annealing of DNA 
strands following strand breakage during re-
combination and chromosomal condensation; and 
in the disentanglement of intertwined DNA strands 
during mitosis (Champoux, 2001; Wang, 2002). HS 
charge-mediated interactions represent a potential 
means whereby chromatin structure, nucleosomal 
function and thus gene expression are regulated 
(Buczek-Thomas et al., 2008).
regulation of intervertebral disc homeostasis by 
the wnt signalling pathway
In humans, 19 Wnt protein family members act as 
morphogens establishing long-range concentration 
gradients that facilitate differential effects on cells 
depending on the cells location within the Wnt 
gradient (Rao and Kühl, 2010). Wnt proteins bind 
to perlecan domain II, which transport the Wnts 
in tissues and aids in the establishment of Wnt 
concentration gradients (Matsuo and Kimura-
Yoshida, 2014). This is an important role for perlecan 
in tissue morphogenesis, Wnt family members 
are palmitoylated signalling glycoproteins with 
relatively poor solubility; however, these lipid-
modified proteins bind with high affinity to perlecan 
domain II which maintains their solubility and allows 
perlecan to act as a Wnt transporter PG (Willert 
and Nusse, 2012). β-catenin is a key mediator of 
Wnt signalling (Willert and Nusse, 1998), perlecan 
fig. 11. 3D rendered image stack of Af chondron 
showing perlecan immunolocalisation .  (a) 
3D rendered image stack showing perlecan 
immunolocalisation (red) associated with a string of 
outer AF chondrons. Nuclear counterstaining in blue. 
3D volume indicated by white boundary box. Note 
intimate association of perlecan with the cell nuclei 
(b,c) in 3D reconstructions of NP chondrons. The 
pericellular matrix and collagenous capsule of the 
chondron are highlighted. Asterisk denotes punctate 
labelling of perlecan associated with chondron. N.B. 
punctate labelling associated with cell nucleus is 
less conspicuous due to overlying structures. Scale 
bars 25 µm.
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regulates Wnt signalling in Drosophila (Kamimura et 
al., 2013; Lindner et al., 2007) and humans (Lord et al., 
2014). The Wnt pathway is an important regulatory 
pathway in the IVD with key roles in IVD cell 
differentiation, morphogenesis, tissue remodelling/
repair, and the control of IVD homeostasis (Clevers 
et al., 2014; Kahn, 2014; Logan and Nusse, 2004). 
Wnt signalling is activated in IVD degeneration 
(Wang et al., 2012) contributing to decreases in ECM 
production, senescence, and apoptosis of NP cells 
(Cully et al., 2013; Hiyama et al., 2010; Roberts et al., 
2006). Wnt-β catenin signalling is implicated in the 
increased degradation of IVD components in vivo 
through an elevation in the levels of MMP-1, MMP-
2, and MMP-9 activity (Hiyama et al., 2013; Hoyland 
et al., 2008) and in fibrotic IVD changes mediated 
through interactions with TGF-β (Lord et al., 2018; 
Piersma et al., 2015; Sun et al., 2015; Zhou et al., 2012).
fig. 12. pCm organisation in np chondron cells. (a, d-g) Matrix organisation of disc chondrons from the 
NP. (b,c) AF dual labelled for perlecan (red) and type VI collagen (green). Cell nuclei shown in blue. (a) 
Colocalisation of type VI collagen and perlecan within the pericellular matrix of a NP chondron denoted by 
white overlay mask. (b-g) Surface-rendered 3D reconstructions, showing the organisation of perlecan and 
type VI collagen within disc chondrons. (b and e) The type VI collagen labelling pattern (green) has been 
rendered semi-transparent to show details of the underlying perlecan organisation (orange-red). (d) the 
cell contents have been lost from the lacuna during histological processing. Pericellular perlecan, lining the 
unoccupied lacuna, can be seen intimately associated with the type VI collagen within the capsular matrix. 
(d-g) boxed ROIs show detail of budding perlecan protrusions at the innermost surface of the chondron 
capsule, i.e. adjacent to the plasma membrane. Fig. modified from (Hayes and Melrose, 2019) under the terms 
of the CC-BY-SA license. Copyright 2016, The Authors.
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nuclear heparanase
Nuclear heparanase, as part of an active chromatin 
complex, regulates mitotic spindle formation and 
maintains chromosome stability (Yang et al., 2018). 
Heparanase degrades nuclear SDC-1 and enhances 
histone acetyl transferase aiding genes which 
aggressively promote tumour progression.
The regulatory roles of HIF-1α in the nucleus of 
np and Af cells
HIF-1α is a key transcriptional factor in the IVD that 
is activated by hypoxia and may also be essential for 
the regulation of nuclear heparanase activity (He et 
al., 2004). Blocking the NF-κB signal transduction 
pathway also decreases heparanase mRNA 
expression in vitro (Andela et al., 2000), thus NF-κB 
may also regulate heparanase in vivo. Degradation 
of nuclear SDC-1 by heparanase enhances histone 
acetyltransferase activity and promotes expression 
of genes that aggressively drive the attainment of 
a tumour phenotype (Purushothaman et al., 2011). 
Prolyl-4-hydroxylase controls the transactivation of 
NF-κB/p65 (Li et al., 2015) and enhances the catabolic 
effects of inflammatory cytokines on cells in the NP. 
Expression of the PHDs is selectively controlled 
by HIF-1 and HIF-2 in NP cells (Fujita et al., 2012) 
thus HIF-1 and 2 also indirectly regulates NF-κB 
and heparanase activity, and also now potentially 
perlecan.
Regulation of pro-inflammatory cytokines by 
HIF-1α, MMPs and ADAMTS-4, 5 through 
sDC-4 and how it impacts on intervertebral disc 
degeneration
Pro-inflammatory cytokines, such as TNF-α and 
IL-1β, upregulate MMP and ADAMTS expression 
in the IVD and, when activated, these result in 
IVD degeneration and failure of the functional 
biomechanical properties of the IVD (Roughley, 2004). 
During IVD degeneration, increased ADAMTS-4 
and ADAMTS-5 activity results in an imbalance in 
anabolic and catabolic events in the IVD and cleavage 
and clearance of aggrecan results in impaired 
biomechanical competence in the degenerate IVD 
(Wang et al., 2011). Inflammatory cytokines such as 
TNF-α and IL-1β result in an upregulation of SDC-4 
synthesis in NP cells (Fears and Woods, 2006). SDC-
4 selectively interacts with pro-ADAMTS-5 at the 
cell surface promoting its activation and aggrecan 
degradation (Mwale, 2014; Wang et al., 2011). SDC-
4 and ADAMTS-5-generated aggrecan neoepitope 
levels show a strong correlation with aggrecan 
depletion in the IVD and with IL-1β and TNF-α 
levels showing the interdependence of all of these 
components in IVD degeneration (Binch et al., 2016). 
The PHD-HIF-1 axis controls expression of SDC-4 
in NP cells (Fujita et al., 2014). Thus HIF-1α not only 
provides cell survival properties to the IVD but it also 
regulates disc degeneration.
Conclusions
As far as is known, this is the first study to 
immunolocalise perlecan intracellularly within IVD 
cells and thus identify a potentially novel regulatory 
area for this multifunctional HS PG within the disc. 
Several perlecan ligands are also known to be nuclear 
and cytoplasmic components (Wnt, FGF2, FGFR1); 
however, it is not known if these interact with 
nuclear perlecan in the same way as they interact 
with perlecan in the PCM. Future experimental 
research on the IVD should examine this possibility 
and determine the physiological significance of 
such interactions. This may open up a new arena of 
cellular regulation and provide novel avenues for the 
treatment of disc degeneration and the alleviation of 
low back pain.
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